source
- Biotech Index Retraces Gains as Weak Trial Data and Market Fears WeighBioPharma Dive’s latest data‑visualization piece examines why biotech stocks have slipped recently and highlights the rapid pace of startup acquisitions this year. The XBI index, a barometer for b…
- FDA week: HHS launches vaccine injury study, midterms may reshape oversight committees, and patent thickets threaten genericsThe Department of Health and Human Services announced a new agency‑wide effort to examine and address injuries that may be linked to vaccines. The initiative will coordinate research across FDA and…